PPARA and type 2 diabetes mellitus: Based on network pharmacology and molecular docking, this study revealed the key targets of Rk1+Rg5 intervention in T2DM, as well as the main signaling pathways (the insulin resistance signaling pathway, cAMP signaling pathway, PPAR signaling pathway, and p53 signaling pathway).